2
Industrial Growth Healthcare Roy Seroussi | Investment Partner | [email protected] Joe Rooney | Investment Partner | [email protected] Aaron Wolfe | Investment Partner | [email protected] George Abd | Operating Partner | [email protected] John Televantos | Senior Partner | [email protected] Tim Zappala | Senior Partner | [email protected] Brian Orkin | Investment Partner | [email protected] Sal Gagliardo | Operating Partner | [email protected] Steve McLean | Senior Partner | [email protected] Gene Gorbach | Investment Partner | [email protected] John DiGiovanni | Investment Partner | [email protected] David Spaight | Operating Partner | [email protected] Michael Bernstein | Operating Partner | [email protected] BG Porter | Operating Partner | [email protected] John Mattison, M.D. | Operating Partner | [email protected] Jeremy Goldberg | Operating Partner | [email protected] Industrial Growth Providers of specialty chemicals and materials that provide solutions to meet the growing demand for improved functionality, efficiency, and performance of end markets. Sub-sectors of interest: • Coatings Adhesives & Sealants • Formulated Polyurethanes • Polymer Additives Composites & High Performance Materials Specialty Packaging & Films Specialty Fluids & Lubricants Healthcare Providers of services to three major healthcare markets: • Pharma Services Specialty Care Delivery Business Services to Providers and Payers Target Area of Focus Preferred Company Characteristics (currently investing Fund V with $2.4 billion in capital commitments) Equity investments in companies with potential for accelerated growth Companies with the capacity to utilize $50 million to $300 million of equity, including add-on acquisitions Initial platform EBITDA of $10mm+ Strategic add-on acquisitions — no minimum size Arsenal Capital Partners is a specialized private equity firm with a deep focus in two sectors, industrials and healthcare. Since its founding in 2000, Arsenal has completed more than 150 transactions, including platform portfolio companies and follow-on acquisitions. Firm Overview

Firm Overview - cms.arsenalcapital.com

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Industrial Growth HealthcareRoy Seroussi | Investment Partner | [email protected]

Joe Rooney | Investment Partner | [email protected]

Aaron Wolfe | Investment Partner | [email protected]

George Abd | Operating Partner | [email protected]

John Televantos | Senior Partner | [email protected]

Tim Zappala | Senior Partner | [email protected]

Brian Orkin | Investment Partner | [email protected]

Sal Gagliardo | Operating Partner | [email protected]

Steve McLean | Senior Partner | [email protected]

Gene Gorbach | Investment Partner | [email protected]

John DiGiovanni | Investment Partner | [email protected]

David Spaight | Operating Partner | [email protected]

Michael Bernstein | Operating Partner | [email protected]

BG Porter | Operating Partner | [email protected]

John Mattison, M.D. | Operating Partner | [email protected]

Jeremy Goldberg | Operating Partner | [email protected]

Industrial Growth

Providers of specialty chemicals and materials that provide solutions to meet the growing demand for improved functionality, efficiency, and performance of end markets. Sub-sectors of interest:

• Coatings

• Adhesives & Sealants

• Formulated Polyurethanes

• Polymer Additives

• Composites & High Performance Materials

• Specialty Packaging & Films

• Specialty Fluids & Lubricants

Healthcare

Providers of services to three major healthcare markets:

• Pharma Services

• Specialty Care Delivery

• Business Services to Providers and Payers

Target Area of Focus

Preferred Company Characteristics (currently investing Fund V with $2.4 billion in capital commitments)

• Equity investments in companies with potential for accelerated growth

• Companies with the capacity to utilize $50 million to $300 million of equity, including add-on acquisitions

• Initial platform EBITDA of $10mm+

• Strategic add-on acquisitions — no minimum size

Arsenal Capital Partners is a specialized private equity firm with a deep focus in two sectors, industrials and healthcare. Since its founding in 2000, Arsenal has completed more than 150 transactions, including platform portfolio companies and follow-on acquisitions.

Firm Overview

100 Park Avenue, 31st FloorNew York, NY 10017

P. 212.771.1717arsenalcapital.com

Current Portfolio Companies

WCG (WIRB-Copernicus Group) is a clinical services organization ensuring safety, transparency, and accelerating progress of clinical research.

Pharma Value Demonstration is the formation of new company that provides services to improve patient health by accelerating and optimizing access to medical advances.

Hopebridge is a center-based provider of ABA therapy for children affected by Autism Spectrum Disorder.

CellCarta provides a full suite of immune monitoring and biomarker development services to biopharmaceutical customers globally.

Accumen is a provider of optimization services and solutions to in-house hospital laboratories and imaging departments.

Best Value Healthcare is a risk-based primary care platform focused on Medicare Advantage and Medicare lives operating in Central and South Florida.

BioIVT is a provider of biospecimens and other value-added biological products and services.

Healthcare

Revolution is a closed-loop manufacturer of post-consumer resin.

Seal for Life is a specialty infrastructure coatings platform.

Polyventive is a provider of specialty construction and textile chemical solutions.

Polytek is a formulated polymer technology platform.

Applied Adhesives is a manufacturer and value-added distributor of adhesive products.

Fralock is a provider of specialty engineered polymer components and films.

Meridian Adhesives is a global manufacturer of adhesives and sealants.

Chroma Color Corporation is a supplier of color concentrates and additives for the plastics market.

Airnov is a manufacturer of desiccant and oxygen scavenging products.

CPS Performance Materials is a manufacturer of diversified performance polymers.

Fenzi is a provider of glass processing technologies and solutions.

Industrial Growth

Includes all realized investments since 2010

Realized Investments

Pharma Value Demonstration